GIMBHI’s daily mental health update — 10/21/26

📋 Brellium raises $23M and debuts CortexLM to audit 100% of clinical notes for compliance (Brellium, Business Wire) — 10/13/26
TL;DR: NYC-based Brellium raised $23M led by Left Lane Capital and First Round to expand CortexLM, its AI chart-auditing system that has reviewed 22M visits and protected ~$2B in provider revenue across clients like Headspace, Rula, and Gentiva.

💊 Outro raises $7M to build neuroscience-based deprescribing platform for psychiatric medications (Jasmine Pennic, HIT Consultant) — 10/12/26
TL;DR: Outro raised $7M across pre-seed and seed led by Listen Ventures to scale its 14-state hyperbolic tapering platform combining specialized clinicians, remote monitoring, and psychosocial support for safely stopping SSRIs, SNRIs, and benzodiazepines.

🏳️‍🌈 Allswell raises $7M to scale LGBTQ+-focused behavioral health platform (Eve Bender, MobiHealthNews) — 10/15/26
TL;DR: San Francisco-based Allswell closed a $7M seed led by ReThink Impact to expand its virtual therapy, group programs, and trauma-informed care for LGBTQ+ patients across DC, Virginia, and Maryland, with plans to add psychiatric medication management.

🔗 Zocdoc acquires Sohar Health in first-ever acquisition to automate insurance eligibility checks (Cailey Gleeson, Fierce Healthcare) — 10/14/26
TL;DR: Zocdoc made its first acquisition in nearly 20 years, buying longtime partner Sohar Health, whose APIs automate insurance discovery, eligibility, and benefits verification across Zocdoc’s 200,000+ provider network.